HDIX: Home Diagnostics Inc - Full Company Report
Enter Ticker:
HOME DIAGNOSTICS, INC., based in Fort Lauderdale, Florida, is a leading developer, manufacturer and marketer of diabetes management solutions. Home Diagnostics, Inc. offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics, Inc. product line includes TRUEtrack, Sidekick, TRUEread and Prestige Smart System blood glucose monitoring systems. Home Diagnostics, Inc. also works closely with hospitals and long-term care facilities to help them more affordably monitor and manage their patients with diabetes.
General Information
HOME DIAGNOSTIC
2400 NW 55th Courtwww.homediagnosticsinc.com nlaudico@theruthgroup.com
Industry
MED PRODUCTS
Sector:
Medical
Fiscal Year End
December
Last Reported Quarter
09/30/09
Next EPS Date
03/09/2010
Price and Volume Information
Zacks Rank
Yesterday's Close
6.27
52 Week High
7.71
52 Week Low
4.58
Beta
0.16
20 Day Moving Average
18,295.60
Target Price Consensus
7.63
% Price Change
4 Week
-4.57
12 Week
3.99
YTD
25.96
% Price Change Relative to S&P 500
4 Week
-5.60
12 Week
-1.96
YTD
4.24
Share Information
Shares Outstanding (millions)
16.88
Market Capitalization (millions)
105.65
Short Ratio
12.71
Last Split Date
N/A
Dividend Information
Dividend Yield
0.00%
Annual Dividend
$0.00
Payout Ratio
0.00
Change in Payout Ratio
0.00
Last Dividend Payout / Amount
NA / $0.00
EPS Information
Current Quarter EPS Consensus Estimate
0.14
Current Year EPS Consensus Estimate
0.32
Estimated Long-Term EPS Growth Rate
18.50
Next EPS Report Date
03/09/2010
Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)
2.60
30 Days Ago
2.60
60 Days Ago
2.60
90 Days Ago
2.60
Fundamental Ratios
P/E
Current FY Estimate:
19.69
Trailing 12 Months:
23.18
PEG Ratio
1.06
EPS Growth
vs. Previous Year
-29.17%
vs. Previous Quarter
54.55%
Sales Growth
vs. Previous Year
-2.99%
vs. Previous Quarter:
5.65%
Price Ratios
Price/Book
0.94
Price/Cash Flow
7.81
Price / Sales
0.87
ROE
09/30/09
4.34
06/30/09
5.81
03/31/09
6.56
ROA
09/30/09
3.42
06/30/09
4.57
03/31/09
5.15
Current Ratio
09/30/09
2.39
06/30/09
2.50
03/31/09
2.26
Quick Ratio
09/30/09
1.77
06/30/09
1.92
03/31/09
1.64
Operating Margin
09/30/09
3.97
06/30/09
5.26
03/31/09
5.87
Net Margin
09/30/09
5.92
06/30/09
7.61
03/31/09
7.57
Pre-Tax Margin
09/30/09
5.92
06/30/09
7.61
03/31/09
7.57
Book Value
09/30/09
6.67
06/30/09
6.63
03/31/09
6.23
Inventory Turnover
09/30/09
3.24
06/30/09
3.20
03/31/09
3.30
Debt-to-Equity
09/30/09
0.00
06/30/09
0.00
03/31/09
0.00
Debt to Capital
09/30/09
0.00
06/30/09
0.00
03/31/09
0.00
Sponsored Links 
-0.01